224 related articles for article (PubMed ID: 9179213)
1. Possible role of FDG-PET in the evaluation of urologic malignancies.
Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
[TBL] [Abstract][Full Text] [Related]
2. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
[TBL] [Abstract][Full Text] [Related]
3. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
5. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
[No Abstract] [Full Text] [Related]
6. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
8. PET-imaging in tumors of the reproductive trac.
Reinhardt MJ; Matthies A; Biersack HJ
Q J Nucl Med; 2002 Jun; 46(2):105-12. PubMed ID: 12114873
[TBL] [Abstract][Full Text] [Related]
9. The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.
Avril N; Dambha F; Murray I; Shamash J; Powles T; Sahdev A
Int J Urol; 2010 Jun; 17(6):501-11. PubMed ID: 20370848
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography in urologic oncology.
Shvarts O; Han KR; Seltzer M; Pantuck AJ; Belldegrun AS
Cancer Control; 2002; 9(4):335-42. PubMed ID: 12228759
[TBL] [Abstract][Full Text] [Related]
11. [Value of computer tomography in staging urological tumors before radical surgery].
Romics I; Will C; Beutler W; Bach D
Orv Hetil; 1991 Dec; 132(50):2779-81. PubMed ID: 1823099
[TBL] [Abstract][Full Text] [Related]
12. [Accuracy of computed tomography in urological tumour diagnosis (author's transl)].
Latal D; Kuber W; Imhof H; Küster W
Wien Klin Wochenschr; 1981 Jun; 93(13):415-20. PubMed ID: 7269622
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and monitoring of urological tumors using positron emission tomography.
Hofer C; Kübler H; Hartung R; Breul J; Avril N
Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography in oncourology].
Ryzhkova DV; Granov AM; Karelin MI; Kostenikov NA; Shkol'nik MI; Tlostanova MS; Stanzhevskiĭ AA; Arzumanov AA
Vestn Ross Akad Med Nauk; 2005; (9):26-32. PubMed ID: 16250328
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography in diagnosis of renal cell carcinoma].
Bachor R; Kotzerke J; Gottfried HW; Brändle E; Reske SN; Hautmann R
Urologe A; 1996 Mar; 35(2):146-50. PubMed ID: 8650849
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in urological oncology.
Hoh CK; Seltzer MA; Franklin J; deKernion JB; Phelps ME; Belldegrun A
J Urol; 1998 Feb; 159(2):347-56. PubMed ID: 9649238
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of the indication for lymphangiography in urological tumor patients (author's transl)].
Rübben H; Lutzeyer W
Urologe A; 1981 Jan; 20(1):31-7. PubMed ID: 7013234
[TBL] [Abstract][Full Text] [Related]
18. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
19. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose.
Heicappell R; Müller-Mattheis V; Reinhardt M; Vosberg H; Gerharz CD; Müller-Gärtner H; Ackermann R
Eur Urol; 1999 Dec; 36(6):582-7. PubMed ID: 10559612
[TBL] [Abstract][Full Text] [Related]
20. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Wahl RL; Quint LE; Greenough RL; Meyer CR; White RI; Orringer MB
Radiology; 1994 May; 191(2):371-7. PubMed ID: 8153308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
